The global nanomedicine market was valued at USD 207.91 billion in 2025 and is projected to reach USD 581.2 billion by 2034, expanding at a 12.1% CAGR from 2025 to 2034, according to Maximize Market Research. Nanomedicine, which applies nanoscale technologies to diagnosis and treatment, spans diagnostics and imaging, drug delivery, vaccines, regenerative medicine, implants and other healthcare applications. Growth is being supported by the rising prevalence of chronic and complex diseases, demand for targeted therapies, personalized medicine adoption and advances in nanoparticle platforms, lipid nanoparticles, liposomes, nanocarriers, nanobiosensors and precision therapeutics. North America held the largest market share in 2025, while Asia Pacific is identified as a high-growth region. Key restraints include high research, clinical development and manufacturing costs, complex regulatory requirements, limited specialized infrastructure and shortages of skilled expertise. The report covers product type, application, indication and regional segments, with forecasts spanning 2026 to 2034 and historical data covering 2020 to 2025.